Epidermal growth factor receptor

Mar 05, 2018

Benitec Biopharma Launches its Phase 2 Oncology Study in Australia

Mar 01, 2018

EnGeneIC Announces Publication of Preclinical Data Highlighting Potential Efficacy of EGFR-Targeted EDV(TM) Nanocells to Treat Pediatric Neuroblastoma

Feb 22, 2018

Benitec Biopharma reports financial results for the 2018 fiscal second quarter and provides operational update

Jan 18, 2018

QIAGEN Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer

Jan 16, 2018

FDA approves new indication for Gilotrif® in EGFR mutation-positive NSCLC

Jan 09, 2018

BerGenBio Meets First Efficacy Endpoint in Phase II Trial With Selective AXL Inhibitor BGB324 (bemcentinib) in NSCLC

Dec 12, 2017

Boehringer Ingelheim initiates real-world study of treatment sequencing in EGFR mutation-positive lung cancer

Sep 27, 2017

Highly Sensitive Assessment Of Common Somatic Mutations In Pulmonary Non-Small Cell Carcinoma With The MassARRAY® System

Sep 26, 2017

OncoBEAM[TM] EGFR Kit (RUO) at Jessenius Medical Faculty of Comenius University and its University Hospital, in Martin, Slovakia

Jun 21, 2017

Avant Diagnostics Appoints Philippe Goix, PhD, MBA as President & CEO to Commercialize Proprietary Theralink® Tumor Biomarker Platform

Jun 12, 2017

Trovagene Enters Into Agreement with AstraZeneca to Utilize Trovera® ctDNA Test and Services in Prospective Biomarker Study